학술논문

Bone morphogenetic protein 2 is a new molecular target linked to non-alcoholic fatty liver disease with potential value as non-invasive screening tool.
Document Type
Article
Source
Biomarker Research; 5/25/2022, Vol. 10 Issue 1, p1-10, 10p
Subject
BONE morphogenetic proteins
NON-alcoholic fatty liver disease
FATTY liver
BIOPSY
HOMEOSTASIS
Language
ISSN
20507771
Abstract
Copyright of Biomarker Research is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)